Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Nippon India Nifty Pharma ETF |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
0.23 |
Equity |
99.74 |
Trep |
0.03 |
|
|
Concentration Analysis |
Top 5 Holdings |
58.54% |
Top 10 Holdings |
78.86% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
99.74 |
Cash |
0.26 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
4.82 |
PE Ratio |
33.14 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
22.48 |
Cipla Limited |
10.68 |
DIVI LABORATORIES LTD |
10.23 |
Dr Reddys Laboratories Limited |
9.45 |
Lupin Limited |
5.70 |
Torrent Pharmaceuticals Limited |
4.78 |
Laurus Labs Limited |
4.18 |
Glenmark Pharmaceuticals Limited |
3.93 |
Aurobindo Pharma Limited |
3.89 |
Mankind Pharma Limited |
3.54 |
Alkem Laboratories Limited |
3.31 |
Zydus Lifesciences Limited |
2.96 |
Biocon Limited |
2.87 |
IPCA Laboratories Limited |
2.50 |
Abbott India Limited |
2.19 |
Gland Pharma Limited |
2.01 |
J B Chemicals and Pharma Ltd |
1.75 |
Ajanta Pharma Limited |
1.41 |
Natco Pharma Limited |
1.04 |
Granules India Limited |
0.84 |
Net Current Assets |
0.23 |
Tri Party Repo |
0.03 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|